ReviewPediatric endocrinology, diabetes, and metabolism2025
Depressive and anxiety disorders in children and adolescents with selected endocrine diseases.
Review in Pediatric endocrinology, diabetes, and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanisms of aerobic exercise effects on the gut microbiota and its metabolites in anxiety disorders.Frontiers in microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depressive and anxiety disorders are among the most common mental health issues in children and adolescents, significantly affecting psychosocial development, school functioning, and quality of life. Patients with chronic endocrine conditions are considered a particularly vulnerable group. The aim of this study was to review the prevalence and characteristics of depressive and anxiety symptoms among pediatric patients with selected endocrine disorders: growth hormone deficiency (GHD), congenital adrenal hyperplasia (CAH), Graves' disease (GD), Hashimoto's thyroiditis, and central precocious puberty (CPP). A search of the PubMed database was conducted in March and April 2025 for original studies published within the last 10 years, focusing on patients aged 0-18 with the listed conditions. Fourteen studies meeting inclusion criteria were analyzed. A standardized search strategy combining Medical Subject Headings (MeSH) and free-text terms was used, and data were extracted regarding methodology, diagnostic tools, and key outcomes. Children with GHD, CAH, GD, Hashimoto's disease, and CPP had a significantly higher prevalence of depressive and/or anxiety symptoms. In some cases, symptom severity correlated with hormonal parameters (e.g., TRAb, anti-TPO). Most studies were limited by small sample sizes and heterogeneous assessment tools. Pediatric patients with endocrine disorders are at increased risk for anxiety and depressive disorders. Multicenter prospective studies using validated instruments are urgently needed. Integration of psychological assessment into endocrine care should be considered standard.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.